Akero Therapeutics Inc.

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

In a filing, Akero Therapeutics Inc revealed its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.51 million

Stock Earnings

In a filing, Akero Therapeutics Inc revealed its President and CEO Cheng Andrew unloaded Company’s shares for reported $2.0 million

Stock Earnings

Akero Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Young Jonathan unloaded Company’s shares for reported $0.28 million

Analysts Viewpoint

Akero Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Young Jonathan unloaded Company’s shares for reported $0.28 million

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akero Therapeutics

Tag: Akero Therapeutics Inc.